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Abstract
Background:  Research evidence from observational studies suggests that cognitive activity
reduces the risk of cognitive impairment in later life as well as the rate of cognitive decline of people
with dementia. The Promoting Healthy Ageing with Cognitive Exercise (PACE) study has been
designed to determine whether a cognitive activity intervention decreases the rate of cognitive
decline amongst older adults with mild cognitive impairment (MCI).
Methods/Design: The study will recruit 160 community-dwelling men and women aged 65 years
of age or over with mild cognitive impairment (MCI). Participants will be randomly allocated to two
treatment groups: non-specific education and cognitive activity. The intervention will consist of ten
90-minute sessions delivered twice per week over a period of five weeks. The primary outcome
measure of the study is the change from baseline in the total score on the Cambridge Cognitive
Score (CAMCOG). Secondary outcomes of interest include changes in memory, attention,
executive functions, mood and quality of life. Primary endpoints will be collected 12, 52 and 104
weeks after the baseline assessment.
Discussion: The proposed project will produce the best available evidence on the merits of
increased cognitive activity as a strategy to prevent cognitive decline among older adults with MCI.
We anticipate that the results of this study will have implications for the development of evidence-
based preventive strategies to reduce the rate of cognitive decline amongst older people at risk of
dementia.
Trial registration: ACTRN12608000556347
Background
The World's population is ageing rapidly and so is the fre-
quency of age-related disorders. Dementia is one of the
most frequent mental health disorders of older people
and a leading cause of years of life lost due to disability
[1]. Mild Cognitive Impairment (MCI) in old age is con-
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sidered an important clinical state potentially predictive
of future cognitive decline. The term MCI has been used
to describe a heterogeneous group of older adults, who,
whilst not fulfilling diagnostic criteria for dementia, dem-
onstrate cognitive abilities at a level below what is consid-
ered normal for their age. Cognitive deficits may be
apparent across unitary or multiple domains though the
person continues to maintain a high level of functional
independence [2]. Whilst this diagnostic group is at
increased risk for conversion to dementia, a substantial
number of individuals remain stable or even return to
normal levels of functioning with time [3].
There is increasing evidence that the onset of dementia
can be delayed by targeting relevant risk factors. In older
adults, frequent participation in mentally stimulating lei-
sure activities has been associated with stronger cognitive
abilities (such as memory) and reduced risk of dementia
[4,5]. The idea that mentally stimulating activity can influ-
ence cognitive processes is akin to the "use it or lose it"
adage [6]. Few randomised controlled studies have
explored this notion and critical evaluation of the research
on this topic reveals a number of methodological limita-
tions. These include the specific nature of some of the par-
ticipant cohorts, the tests used to measure cognitive
functioning, and the complexity associated with identify-
ing and defining a broad range of leisure activities with
regard to type and degree of cognitive stimulation (see [6]
for a review).
Cognition-focused interventions (cognitive training, cog-
nitive rehabilitation and cognitive stimulation) attempt
to make use of intact domains to help maintain cognition
and prevent/delay decline. These techniques have also
been employed to increase functional independence and
reduce caregiver burden (see [7] for a review).
Similar to mentally stimulating leisure activities, cognitive
stimulation (CS) is a type of intervention that emphasises
the benefits of group activities focussing on education,
discussion and debate, and problem solving. In contrast,
cognitive rehabilitation (CR) can be tailored towards an
individual's needs, with consideration given to specific
areas of impairment and an emphasis on improving eve-
ryday functioning. Another commonly used strategy is
cognitive training (CT), which aims to provide the indi-
vidual with a set of standardised tasks that they repeatedly
perform. CT using specifically designed computer pro-
grams has become a burgeoning business and is generat-
ing increasing scientific interest.
Collectively, the research in this area has revealed that
older adults (with and without dementia) show modest
gains across areas related to the target intervention, and
improvements on subjective measures assessing aspects of
mood and quality of life have also been observed [8].
However, there is a paucity of randomised controlled tri-
als in this area, limiting conclusions that can be drawn
from existing data.
We have designed a single-blind, randomised controlled
trial of an intervention that draws on methods of cogni-
tion-focussed approaches, selected with regard to suitabil-
ity for older adults with MCI, and combined into a
package considered interesting, engaging and acceptable
to this group. The primary focus of this research is to
determine whether a structured program of cognitive
activity (CA) can decrease the rate of cognitive decline
amongst older adults with MCI over 24 months. We
hypothesize that participants allocated to the CA group
will experience less cognitive decline than older adults
randomised to a control education intervention.
Methods/Design
Background
The Promoting Healthy Ageing with Cognitive Exercise
(PACE) study is a randomised controlled trial that com-
menced recruitment of participants in March 2007.
In late 2006, eight individuals with MCI, aged 60 years
and over, were invited to offer their opinions regarding
the development of a program of cognitive activity (CA),
specifically designed for older adults with cognitive
decline. The group confirmed the merit of such research
and provided feedback with respect to the elements
needed to be incorporated into the designed intervention.
The general consensus was that any CA program needed
to be challenging, personally stimulating and to have a
social component.
In February 2007, the CA and educational interventions
forming the basis of the PACE study were piloted with 10
participants (five allocated to each intervention), aged 65
and over with MCI. These individuals attended on a daily
basis over a two week period and were asked to provide
written feedback regarding the session material. The pro-
posed interventions were well received, with positive feed-
back regarding the relevance of the content/material,
format and delivery style. The education group described
the program as "useful" and "informative" and the CA
group, "encouraging" and "practically helpful". After col-
lating the feedback, additional, minor modifications were
made to the study protocol and recruitment began.
Participants
Recruitment of older persons
Participants were community dwelling volunteers
recruited from various sources such as memory clinics,
local media and other ongoing research studies. Potential
participants were initially screened with a semi-structuredTrials 2009, 10:114 http://www.trialsjournal.com/content/10/1/114
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interview over the telephone and invited to visit the West-
ern Australia Centre for Health and Ageing (WACHA),
Royal Perth Hospital (RPH) for a more detailed screening
assessment (clinical screen) and to provide written
informed consent. The Ethics Committee of the RPH has
approved the study protocol and procedures.
Inclusion and Exclusion Criteria
The most important defining feature of participants
included in the PACE study was a diagnosis of MCI, which
was ascertained at a screening assessment at the WACHA
(discussed in further detail below). Individuals needed to
be aged 65 years or over at their last birthday and be will-
ing and able to travel to the WACHA. All were proficient
in spoken and written English. Individuals with a diagno-
sis of dementia according to ICD-10 criteria for Research
[9] or suffering notable cognitive impairment, as evi-
denced by a Mini Mental State Examination (MMSE; [10])
score of 23 or less, were excluded from the study. Addi-
tional exclusion criteria included current psychiatric dis-
order (e.g. depressive episode), and current history of
hazardous or harmful alcohol consumption (based on the
Australian Alcohol Guidelines endorsed by the National
Health and Medical Research Council 2001). Those indi-
viduals with a current medical condition that prevented
participation in the study tasks (such as sensory impair-
ment) or was associated with reduced survival over a 12
month period (e.g. advanced cancer) were excluded. We
also excluded from the trial people who reported a clinical
history of stroke associated with permanent disability.
Telephone Interview
Volunteers were initially screened via a telephone inter-
view to ascertain individuals' concerns regarding their
memory. Those indicating that they had received a diag-
nosis of dementia were immediately excluded. The
remainder were then asked about general health - both
past and current concerns - as well as education and Eng-
lish literacy skills. Details regarding current alcohol con-
sumption were also collected and all potential
participants completed the PHQ-9 (see below) and the
TICS-M (see below). Telephone interviews took approxi-
mately 10 to 30 minutes to complete depending on the
extent of information needed to address inclusion and
exclusion criteria. Those meeting provisional criteria for
inclusion were invited to a face-to-face assessment at the
WACHA to confirm that they fulfilled the study criteria.
Patient Health Questionnaire - Nine Item (PHQ-9) [11]
The PHQ-9 is the depression module taken from the full
PHQ [12], an instrument used to make criteria-based
diagnoses of depressive and other mental disorders
according to the DSM-IV. In this study it was used to ini-
tially exclude individuals with depression and then to
monitor the presence of depressive symptoms at follow
up. Scores range from 0 to 27, with scores of 15 or greater
indicative of clinically significant depression. Volunteers
with a score of 15 or more on the PHQ-9 were excluded
from further participation in the study.
The modified Telephone Interview for Cognitive Status (TICS-
M)_[13]
The TICS-M was developed as a dementia screen and con-
tains 21 items, with a total score out of 50. It takes five to
ten minutes to complete and has been used to recruit for
clinical trials by screening for amnestic MCI. In this study,
individuals who obtained scores between 19 or greater
and 38 or less were considered as possible candidates with
MCI and invited to complete the next phase of recruit-
ment. Older adults with scores lower than 19 were
excluded, with this score suggesting the presence of clini-
cally significant cognitive impairment. Those individuals
with scores above the cut-off were also excluded as their
performance suggested relatively intact cognitive func-
tioning.
Clinic Screen
Three-hundred and twenty-four older adults completed
the face-to-face assessment to establish the diagnosis of
MCI according to the following criteria [2]
• Cognitive complaints and reports of decline from
the individual
￿ Cognitive disorder as evidenced by clinical evalua-
tion (impairment in memory and/or in another cogni-
tive domain)
￿ Absence of major repercussions on daily life (the
individual may however report difficulties concerning
complex day to day activities)
￿ Absence of dementia
Cognitive disorder was established by identifying per-
formances 1.5 standard deviations below the age and sex
norms on any Consortium to Establish a Registry for
Alzheimer's Disease (CERAD) cognitive task [14]. The
CERAD is composed of sub-tests assessing language,
memory and praxis and is considered a valid and reliable
measure of cognitive function, as well as MCI and Alzhe-
imer's disease [15]. Embedded within this test battery is
the MMSE. This brief cognitive test is a commonly used
screening instrument that produces a total score that can
range from 0 to 30. Scores lower than 24 are reliably asso-
ciated with the diagnosis of dementia or other organic
mental disorders. The present study also used the MMSE
to exclude participants with more severe cognitive impair-
ment than MCI.
In addition to the cognitive screen, participants were
required to score less than 16 on the World Health Organ-Trials 2009, 10:114 http://www.trialsjournal.com/content/10/1/114
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isation's Alcohol Use Disorders Identification Test
(AUDIT). This self report questionnaire is considered a
reliable screening tool sensitive to the detection of risky,
hazardous or harmful drinking [16]. There are 10 items
and supplementary questions, with questions scored on a
scale of 0 to 4. Scores of 16 or above suggest "high-risk" or
"harmful level" of drinking behaviour.
A self-reported medical history questionnaire was also
completed by the participants and details collected
regarding their medication use. A screen of participants'
ability to manage complex activities of daily living was
conducted using a modified version of the Structured
Assessment of Independent Living Skills (SAILS [17]).
Information regarding the participant's motor skills (fine
and gross), language abilities and capacity to carry out
tasks similar to day to day activities (e.g. money related
skills, following a recipe, reading a calendar) were col-
lected. A score of 150 represented a perfect score and those
individuals with scores of less than 141, suggestive of dif-
ficulties carrying out instrumental activities of daily living,
were excluded.
The screening assessment at the WACHA took approxi-
mately 30 to 40 minutes to complete. Any pertinent clin-
ically information was reported to the relevant treating
physician with the consent of the study participant. Of
those who were screened, 171 met criteria and 160 com-
pleted written informed consent to participate.
Outcome Measures and Assessment Procedures
Baseline Assessment
Baseline assessments were completed within three
months of inclusion in the study, approximately two
weeks prior to the first intervention session and prior to
randomisation. Baseline and post intervention assess-
ments took between 60 to 90 minutes to complete
(including the provision of short breaks), with a two hour
session allocated for the more detailed 12 and 24 month
follow ups. The assessments comprised a series of tests
and questionnaires, and included the following:
Primary outcome measure
Cambridge Cognitive Screen (CAMCOG): This is the brief
neuropsychological battery of the Cambridge Examina-
tion for Mental Disorders of the Elderly - Revised (CAM-
DEX-R) [18] that includes a range of objective cognitive
tests. It provides sub-scale scores for a number of cognitive
domains as well as a global score out of 105. It takes
approximately 30 minutes to administer and is very effec-
tive at differentiating between people with and without
dementia [19]. There is also evidence that CAMCOG
scores are sensitive to change over time [20]. The CAM-
COG is the primary outcome measure of this study.
Secondary Outcome Measures
California Verbal Learning Test-Second Edition (Standard
and Alternate Forms) (CVLT-II) [21]: This is a 16-item
word list task that measures verbal learning and memory.
It yields scores on immediate and delayed recall as well as
recognition. Provision of standard and alternate forms
minimises practice effects and are being used to monitor
change in memory functions. The CVLT-II was chosen as
a secondary outcome measure because low scores on
word list learning tasks are associated with progression to
dementia [22].
The Symbol Search sub-test from the Wechsler Adult Intel-
ligence Scale-Third Edition (WAIS-III) [23] yields a meas-
ure of perceptual processing speed. Participants are asked
to indicate whether target symbols appear in a search
group of symbols. There are 60 items consisting of paired
groups of symbols and the individual has 120 seconds to
complete as many items as possible. Prior research has
found that CA is associated with lower rates of decline on
measures assessing processing ability such as perceptual
speed and working memory [24], supporting the use of
Symbol Search and Digit Span (see below) as an addi-
tional secondary outcome of interest.
The Digit Span sub-test from the WAIS-III [23] comprises
forward and backward span components assessing indi-
viduals' auditory immediate attention and working mem-
ory. The examinee listens to a series of digits given orally
by the examiner and then repeats the digits either in a for-
ward or reverse sequence. Testing is discontinued after
failure on the two trials of any series.
The Trail Making Test (TMT) [25] has two parts and meas-
ures complex visual scanning, motor speed and mental
agility. In Part A the participant draws lines to connect
consecutively numbered circles. Part B requires the partic-
ipant to connect a sequence of numbered and lettered cir-
cles, alternating between the two sequences. The tests are
timed, with participants instructed to complete the
sequencing as quickly as possible.
The Controlled Word Association Test (COWAT) [25]
consists of three word naming trials, with the letters FAS
employed. Participants are asked to say as many words as
they can think of that begin with the given letter of the
alphabet, excluding proper nouns, numbers and the same
word with a different suffix. A minute is given for each let-
ter trial and performance is used as an indicator of execu-
tive functioning.
PHQ-9: We used the PHQ-9 total score, as previously
described, to monitor changes in mood throughout the
trial.Trials 2009, 10:114 http://www.trialsjournal.com/content/10/1/114
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Leisure Activity and Frequency Questionnaire [4]: This
seven-item questionnaire assesses the frequency of partic-
ipation in a variety of mentally stimulating leisure activi-
ties. Given the relationship identified between leisure
activity and cognitive decline [24], the aforementioned
questionnaire was chosen to identify the effects that the
individual's level of activity over the course of the study
may have on their rate of cognitive decline.
Participants also rated their level of engagement in physical
activity [26]. They were asked to indicate how much time
they spent, over a week, taking part in vigorous and non-
vigorous activity. An additional questionnaire was also
added to identify the nature and quality of the partici-
pants' social relationships [27].
The Memory Functioning Questionnaire (MFQ) [28]: The
MFQ is a 64-item questionnaire evaluating self-percep-
tion of everyday memory functioning. It was used at base-
line and across follow-up assessments to determine the
influence of the intervention on perceived level of mem-
ory ability.
The Quality of Life in Alzheimer's Disease (QoL-AD) [29]:
This is a 13-item questionnaire completed by the partici-
pant assessing their perception of their quality of life
across a number of different domains.
Participants were also asked to provide specific details
regarding their educational and occupational back-
ground.
The assessment battery described above was repeated
immediately after the intervention (please see details
below) and again after 12 and 24 months (please see table
1). The 12 and 24 month follow-up assessments were
undertaken relative to the baseline testing and also
included the additional measures administered at the
"Clinic Screen".
Biological Sample and DNA Collection
We also asked participants to donate a blood or saliva
sample to determine the influence of common biochemi-
cal (e.g., high plasma homocysteine) and genetic factors
(e.g., apolipoprotein E4 genotype) on participants'
response to the intervention. The samples are being col-
lected and processed by the Department of Clinical
Pathology and Biochemistry at the RPH where they are
currently stored at -80°C. All material has been batched
and will only be processed at the end of the trial.
Intervention
The interventions (both CA and education) consisted of a
five-week group activity run by a qualified Neuropsychol-
ogist at the WACHA. The CA and control education
groups were exposed to the same length of intervention,
social interaction and contact with the program coordina-
tor. Both the CA and educational intervention were man-
ualised and delivered in a structured way, and all sessions
(220) were audio-taped for subsequent fidelity assess-
ment. Forty four of these sessions were randomly selected
and transcribed. An independent rater used a specially
devised scale to evaluate session content for consistency of
concepts and issues raised across sessions according to a
pre-defined criteria.
Research assistants (RAs) blinded to group allocation con-
ducted all assessments. RAs were provided with strict
instructions to avoid any potential opportunity for disclo-
sure regarding intervention participation. The intention is
that RAs undertaking data collection will be asked to guess
the group membership of participants at the end of the
study. This will be done to determine the effectiveness of
the blinding procedures that were put in place for this
project. A brief summary of each intervention is provided
below.
CA Group
Each group consisted of 6-9 participants who took part in
90-minute sessions twice a week for five weeks (10 ses-
sions in total). Session One introduced the nature of the
program and developed familiarity within the group, with
personal introductions and sharing of background infor-
mation/experiences. Sessions Two and Three focussed on
the cognitive domains of attention, processing speed and
executive functions, how these domains change as people
age and the influence they have on memory abilities. Par-
ticipants were advised about strategies to manage cogni-
tive decline associated with these domains, including a
number of practical exercises. Sessions Four to Seven pri-
marily focused on memory, with the aim of defining the
processes involved in learning and retaining new informa-
tion. These sessions provided participants with strategies
and techniques to manage memory dysfunction. There
was regular opportunity for supervised practice of such
techniques in all sessions. Session Eight reviewed age
associated language difficulties and aimed to provide par-
ticipants with ways to manage word finding difficulties, as
well as affording opportunity for undertaking language-
based exercise activities. Sessions Nine to Ten were used to
practice and review the previously presented material and
recommended strategies, and to discuss any difficulties
managing the strategies/techniques previously presented.
As part of the intervention, all participants received a
folder containing the slides of each session, and copies of
all completed activities.
Education Group
Each educational group consisted of 6 to 9 participants
who took part in 90-minute sessions twice a week for five
weeks (10 sessions in total). Session One followed theTrials 2009, 10:114 http://www.trialsjournal.com/content/10/1/114
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same format described for the CA group. Session Two cov-
ered the topic of memory functioning and dementia, aim-
ing to provide a broad overview of how these issues can
affect older people. Session Three reviewed the health
benefits associated with physical activity and ways to
incorporate physical activity into daily lifestyle. Sessions
Four and Five were devoted to defining stress and depres-
sion as well as reviewing the cause, effects and manage-
ment of these conditions. Session Six outlined changes in
sleep associated with ageing and the management of sleep
disturbance. In sessions Seven to Nine, focus was placed
on issues of retirement including expectations, lifestyle
changes, volunteer activities, cultural/societal implica-
tions of ageing and travelling. Session Ten reviewed the
content of material covered in the previous weeks and
provided opportunity for discussion of any questions/
issues arising from the presented topics. In contrast to the
CA group, there was no emphasis on skill development or
Table 1: Outline of the assessments and timelines of the PACE trial. 
Assessment Tool Telephone Screen Clinical Screen Baseline
(0 weeks)
Post-Intervention
(12 weeks)
12 months
(52 weeks)
24 months
(104 weeks)
TICS-M X
PHQ-9 X X X X X X
CERAD X X X
MMSE X X X
AUDIT X X X
SAILS X X X
MHQ X X X
CAMCOG X X X X
CVLT-II X X X X
Digit Span X X X X
Symbol Search X X X X
TMT X X X X
COWAT X X X X
LAQ X X X X
PAQ X X X X
SNSQ X X X X
MFQ X X X X
QOL-AD X X X X
The X indicates at which point of the trial the respective assessments took place. Follow-up times relate to baseline testing.
A booster telephone call took place at 24 weeks, with a face to face booster at 52 weeks.
TICS-M = The Modified Telephone Interview for Cognitive Status; PHQ-9 = Patient Health Questionnaire - Nine Item; CERAD = Consortium to 
Establish a Registry for Alzheimer's Disease; MMSE = Mini Mental State Examination; AUDIT = Alcohol Use Disorders Identification Test; SAILS = 
Structured Assessment of Independent Living Skills; MHQ = Medical Health Questionnaire; CAMCOG = Cambridge Cognitive Examination; CVLT-
II = California Verbal Learning Test - Second Edition; TMT = Trail Making Tests; COWAT = Controlled Oral Word Association Test; LAQ = 
Leisure Activity Questionnaire; PAQ = Physical Activity Questionnaire; SNSQ = Social Network Satisfaction Questionnaire; MFQ = Memory 
Functioning Questionnaire; QOL-AD = Quality of Life in Alzheimer's Disease.Trials 2009, 10:114 http://www.trialsjournal.com/content/10/1/114
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the promotion of mentally stimulating activities and ses-
sions had a greater level of mental passivity. However, as
in the CA group, there was opportunity for group discus-
sion and interaction and participants were provided with
a folder containing the slides of each session.
Booster Sessions
All participants received a fifteen-minute "booster" tele-
phone call six months after the baseline assessment to
review and discuss the topics presented at the group ses-
sions. Thirty minutes of additional exercise material was
posted to participants in the CA group for completion
prior to the booster call and served as the basis for discus-
sion during the telephone contact. After the 12-month
assessment a face-to-face group 1-hour booster session
was offered to both intervention groups. This session was
used to review the practical aspects of the CA and educa-
tional programs.
Randomisation
After the baseline assessment, participants were randomly
allocated to either the CA or control education interven-
tions according to a random list of numbers generated by
computer. Randomisation was undertaken in random
blocks of 12 to 18, with six to nine individuals allocated
to each group. The allocation list was handled by an inde-
pendent investigator (OPA) who had no contact with
study participants and was not involved in the supervision
of staff responsible for the collection of data. The alloca-
tion table was then passed on to the investigator running
the intervention (MV), who invited eligible participants to
join the relevant groups. Research assistants undertaking
the follow-up assessments remained blinded to group
allocation.
Sample Size and Power Calculation
At present there is no reliable data for calculating the sam-
ple size of the proposed trial. Currently available data sug-
gests that older people living in the community lose 1.6
points per year on the CAMCOG [30]. Factoring in a pos-
sible 20% loss to follow up, with 64 people in each group
we will have 80% power to detect a between-groups differ-
ence of 1.5 points on the CAMCOG. This assumes a
decline that is twice as large in the educational compared
with the cognitive intervention group, and although sta-
tistically this may be associated with moderate effect size
(0.5), it is the minimum difference that one would con-
sider clinically significant.
Analysis of the Data
Changes in the CAMCOG score from baseline are the pri-
mary outcome of interest in the study. We will model
these changes at 3 time points: 12 weeks (immediately
after the intervention comes to an end), 52 and 104
weeks. We will use mixed effects models to analyse the
data. This approach will enable us to take into account the
cognitive performance of participants at baseline, as well
as the intra-person correlation generated from repeated
measures. Intention-to-treat analyses will be based on the
use of imputation by chain equations (ICE), which will
precede the use of the mixed-effects model.
We accept that participation in the cognitively non-spe-
cific educational intervention is likely to have an effect on
the performance of participants. However, to ensure con-
tinued participation of the control group we deemed it
crucial to provide some form of intervention or poten-
tially face differential drop out, with the control group
participants withdrawing because of lack of engagement
in the study. We will model changes over time for both
groups and this will enable us to determine the effect of
both interventions (as well as the sustainability of this
effect over 24 months) on cognitive performance.
Comment
Our group has previously demonstrated that it is possible
to delay cognitive decline in people with MCI by means of
a physical activity program [31]. Observational data and
basic research suggest that cognitive activity is also associ-
ated with decreased risk of cognitive impairment, though
there is limited empirical evidence from randomised trials
that cognitive activity can delay the progression of cogni-
tive decline in people with MCI who are at increased risk
of developing dementia. This trial has been designed
according to CONSORT guidelines and has been struc-
tured to enable its reproduction in both research and clin-
ical settings. We expect to collect the final endpoint by
December 2010 and anticipate that the results of this
study will have implications for the development of evi-
dence-based preventive strategies to reduce the rate of cog-
nitive decline amongst older people at risk of dementia.
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